ClinConnect ClinConnect Logo
Search / Trial NCT00155064

Kallikrein-kinin (KKS) and Renin-angiotensin-aldosterone System (RAAS) in Primary Aldosteronism

Launched by NATIONAL TAIWAN UNIVERSITY HOSPITAL · Sep 9, 2005

Trial Information

Current as of May 27, 2025

Completed

Keywords

Primary Aldosteronism Kallikrein Aldosterone Captopril

ClinConnect Summary

Hypertension affects 20% to 25% of adult population. Most patients are diagnosed as having essential or primary hypertension. Up to 10% to 15 % have an identifiable cause and many of those have an adrenal basis \[Miroslava H. et al., 2002\]. The tissue kallikrein-kinin (KKS) and renin-angiotension-aldosterone system (RAAS) had been implicated in regulating blood pressure and electrolyte homeostasis. Recent studies in humans indicate that the vasodilator tissue KKS, the counterpart of the tissue RAAS, is also expressed in the adrenal gland. The adrenal gland regulates sodium and water excret...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Patients with hypertension admitted for the diagnosis of primary aldosteronism
  • Exclusion Criteria:
  • Pregnant or lactating women. (Pre-menopause women, capable of bearing children will undergo pregnancy test), hypertension without discontinuous b-blocker, ACEI or ARB for more than 10 days.

About National Taiwan University Hospital

National Taiwan University Hospital (NTUH) is a leading medical institution renowned for its commitment to advancing healthcare through innovative research and clinical trials. As a pioneer in medical education and patient care in Taiwan, NTUH integrates cutting-edge technology with comprehensive clinical expertise to facilitate groundbreaking studies across various medical fields. The hospital’s dedicated research team collaborates with local and international partners to enhance the understanding of diseases and improve treatment outcomes. By prioritizing patient safety and ethical standards, NTUH strives to contribute to the global medical community and foster advancements in healthcare practices.

Locations

Taipei, , Taiwan

Taipei, , Taiwan

Patients applied

0 patients applied

Trial Officials

Kwan-Dun Wu, Md, PhD

Study Chair

National Taiwan University Hospital

Vin-Cent Wu, MD

Study Director

National Taiwan University Hospital

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials